Related Experiment Video
Updated: Sep 18, 2025
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.3K
Osteosarcoma: current insights and advances.
Guraustin S Brar1, Aidan A Schmidt1, Logan R Willams2
1Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA.
Exploration of Targeted Anti-Tumor Therapy
|June 23, 2025
Summary
Osteosarcoma, a primary bone cancer in young adults, has a poor prognosis due to aggressive metastasis. This review details current treatments and emerging therapies like gene therapy and immunotherapy to improve outcomes.
Area of Science:
- Oncology
- Orthopedic Oncology
Background:
- Osteosarcoma is the most common primary malignant bone tumor in adolescents and young adults.
- Poor prognosis is linked to aggressive behavior and frequent metastasis at diagnosis.
- Etiology is multifactorial, including genetic, environmental, and familial factors.
Purpose of the Study:
- To provide a comprehensive overview of osteosarcoma.
- To discuss current and evolving treatment modalities.
- To highlight recent therapeutic innovations and future research directions.
Main Methods:
- Comprehensive literature review.
- Synthesis of current research on osteosarcoma.
- Analysis of historical context, classifications, diagnostics, and treatments.
Main Results:
- Neoadjuvant chemotherapy and surgical resection are standard treatments.
- Emerging therapies include gene therapy, immunotherapy, advanced radiation, and tyrosine kinase inhibitors.
- Significant challenges remain in improving patient outcomes.
Conclusions:
- Despite advancements, osteosarcoma prognosis remains challenging.
- Novel therapeutic strategies show promise for improving patient survival.
- Further research is critical to address knowledge gaps and enhance osteosarcoma care.
Related Concept Videos
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:31Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K